Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis
This study is ongoing, but not recruiting participants.
Study NCT00185991   Information provided by Stanford University
First Received: September 12, 2005   Last Updated: November 6, 2008   History of Changes
This Tabular View shows the required WHO registration data elements as marked by

September 12, 2005
November 6, 2008
 
Afebrile at 24 hours and no endometritis
Same as current
Complete list of historical versions of study NCT00185991 on ClinicalTrials.gov Archive Site
Neonatal outcomes
Same as current
 
Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis
Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis

To compare once daily versus 8 hour dosing of gentamicin for the treatment of chorioamnionitis.

 
 
Interventional
Treatment, Randomized, Double-Blind, Active Control, Single Group Assignment, Efficacy Study
Chorioamnionitis
Drug: gentamicin
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Active, not recruiting
0
 
 

Inclusion Criteria::

  • clinical diagnosis of chorioamnionitis
 Exclusion Criteria:- maternal renal disease, intrauterine fetal death, allergy to gentamicin
Female
18 Years and older
No
 
United States
 
 
NCT00185991
 
 
Stanford University
 
Principal Investigator: Yasser Yehia El-Sayed Stanford University
Stanford University
November 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.